Based on 2 analysts giving stock ratings to Medifast Inc in the past month.
In the current month, MED has received 0 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. MED average Analyst price target in the last month is 12.000.
Based on analysts' estimates, MED EPS is projected to reach 0.010 in FY2026Q4, following reported EPS of -1.566 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -1.57, while Medifast IncMED's earnings per share (EPS) for the previous quarter was USD -0.28. EPS for the next quarter is expected at USD 0.01.